Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival

被引:21
作者
Spinola, Monica
Falvella, F. Stefania
Galvan, Antonella
Pignatiello, Carmen
Leoni, Vera P.
Pastorino, Ugo
Paroni, Rita
Chen, Shuqing
Skaug, Vidar
Haugen, Aage
Dragani, Tommaso A.
机构
[1] Ist Nazl Tumori, Dept Expt Oncol & Labs, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Unit Thorac Surg, I-20133 Milan, Italy
[3] Univ Milan, Sao Paolo Hosp, Dept Med Surg & Dent Sci, I-20122 Milan, Italy
[4] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang, Peoples R China
[5] Natl Inst Occupat Hlth, Sect Toxicol, Oslo, Norway
关键词
genetic susceptibility; lung cancer; tumour progression; single-nucleotide potymorphisms; TRIT1; MFSD2;
D O I
10.1016/j.lungcan.2006.10.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Linkage disequilibrium (LD) analysis to refine a region associated with lung cancer progression on chromosome 1p34 identified a 106 kb LD block that includes MYCL1, TRIT1 (tRNA isopentenyltransferase 1) and MFSD2 (major facilitator superfamily domain-containing 2). Case-only association study on SNPs mapping in TRIT1 and MFSD2 indicated that the rare Leu allele (frequency: 0.04) of the TRIT1 Phe202Leu variation predicts short survival as compared to the common Phe/Phe genotype (hazard ratio (HR) = 1.7; 95% CI, 1.03-2.86; P = 0.039) in 335 Italian lung adenocarcinoma samples. A replication study in an independent population of 246 Norwegian lung cancer patients confirmed the significant association of the Phe202Leu polymorphism with patients' survival, but the rare allele was associated with better survival rate (HR = 0.5; 95% CI, 0.26 - 0.91; P = 0.023). The rare allele of TRIT1 Phe202Leu SNP was similar to seven-fold more frequent in Asian than in Caucasian subjects and three additional SNPs in the TRIT1 and MFSD2 genes showed ethnic differences in allelic frequencies. These results suggest that polymorphisms in the MYCL1 LD region affect lung cancer survival but that the functional element(s) may show population-specific patterns. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 18 条
[1]   A COMPARISON OF LINKAGE DISEQUILIBRIUM MEASURES FOR FINE-SCALE MAPPING [J].
DEVLIN, B ;
RISCH, N .
GENOMICS, 1995, 29 (02) :311-322
[2]  
Dragani TA, 2000, CANCER RES, V60, P5017
[3]   Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma [J].
Ge, H ;
Lam, WK ;
Lee, J ;
Wong, MP ;
Yew, WW ;
Lung, ML .
LUNG CANCER, 1996, 15 (03) :355-366
[4]   MOD5 TRANSLATION INITIATION SITES DETERMINE N6- ISOPENTENYLADENOSINE MODIFICATION OF MITOCHONDRIAL AND CYTOPLASMIC TRANSFER-RNA [J].
GILLMAN, EC ;
SLUSHER, LB ;
MARTIN, NC ;
HOPPER, AK .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2382-2390
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]   CLOSE CORRELATION BETWEEN RESTRICTION FRAGMENT LENGTH POLYMORPHISM OF THE L-MYC GENE AND METASTASIS OF HUMAN-LUNG CANCER TO THE LYMPH-NODES AND OTHER ORGANS [J].
KAWASHIMA, K ;
SHIKAMA, H ;
IMOTO, K ;
IZAWA, M ;
NARUKE, T ;
OKABAYASHI, K ;
NISHIMURA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2353-2356
[7]   AMPLIFICATION AND REARRANGEMENT OF L-MYC IN HUMAN SMALL-CELL LUNG-CANCER [J].
MAKELA, TP ;
SAKSELA, K ;
ALITALO, K .
MUTATION RESEARCH, 1992, 276 (03) :307-315
[8]   ASYMPTOTICALLY EFFICIENT RANK INVARIANT TEST PROCEDURES [J].
PETO, R ;
PETO, J .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1972, 135 :185-&
[9]   Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases [J].
Shih, CM ;
Kuo, YY ;
Wang, YC ;
Jian, SL ;
Hsu, YT ;
Wu, HY ;
Guo, MW ;
Wang, YC .
LUNG CANCER, 2002, 36 (02) :125-132
[10]   Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer [J].
Spinola, M ;
Galvan, A ;
Pignatiello, C ;
Conti, B ;
Pastorino, U ;
Nicander, B ;
Paroni, R ;
Dragani, TA .
ONCOGENE, 2005, 24 (35) :5502-5509